Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis

Baricitinib Effects on Procoagulant State in Rheumatoid Arthritis

NCT07357649 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Moderate to Severe Rheumatoid Arthritis Study

NCT01721044 ·Status: COMPLETED ·Phase: PHASE3

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA)

NCT02265705 ·Status: COMPLETED ·Phase: PHASE3

Baricitinib, Methotrexate as Monotherapy or Combination in the Treatment of Rheumatoid Arthritis - an Open Label Randomized Clinical Trial

NCT05827497 ·Status: UNKNOWN ·Phase: PHASE4

Comparative Effectiveness of Targeted Therapy in RA Patients

NCT04449224 ·Status: UNKNOWN

Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.

NCT03605251 ·Status: COMPLETED ·Phase: PHASE2

A Study in Moderate to Severe Rheumatoid Arthritis

NCT01710358 ·Status: COMPLETED ·Phase: PHASE3

An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis

NCT07029555 ·Status: RECRUITING ·Phase: PHASE1

Safety and Retention Rate of the JAK and TNF Inhibitors in Rheumatoid Arthritis: a Real-life Experience

NCT05182203 ·Status: COMPLETED

An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy

NCT00162201 ·Status: COMPLETED ·Phase: PHASE1

Clinical Disease Activity and Modulation of Synovial Lymphoid Structures and B Cell Function in Rheumatoid Arthritis

NCT02528292 ·Status: UNKNOWN

Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging

NCT02683421 ·Status: COMPLETED ·Phase: PHASE1

T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade

NCT01060098 ·Status: COMPLETED

The Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months and Long-term Treatment

NCT02837978 ·Status: COMPLETED ·Phase: PHASE4

To Compare the Efficacy and Safety of Low-dose Glucocorticoids and Tofacitinib in Alleviating Moderate to High Disease Activity Rheumatoid Arthritis for 24 Weeks

NCT05606107 ·Status: UNKNOWN ·Phase: PHASE4

Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients

NCT00124449 ·Status: COMPLETED ·Phase: PHASE2

An Open-label Study of GC012F in Rheumatoid Arthritis.

NCT07315503 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

NCT03915964 ·Status: COMPLETED ·Phase: PHASE4

Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica

NCT06172361 ·Status: RECRUITING ·Phase: PHASE3

Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III)

NCT00664521 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis

NCT05572567 ·Status: COMPLETED

An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis

NCT01885078 ·Status: COMPLETED ·Phase: PHASE3

Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life Conditions

NCT03073109 ·Status: COMPLETED

A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis

NCT03882008 ·Status: COMPLETED ·Phase: PHASE4

Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders

NCT03227419 ·Status: UNKNOWN ·Phase: PHASE4